A diagnosis of leptospirosis: a case report (original) (raw)

Abstract

A 54-year-old male presented with symptoms of fever, rigors, myalgia, dry cough, and dyspnea. Ten days earlier, he described a condition resembling an upper respiratory infection. The measured body temperature was 38.20°C. Scleral icterus, jaundice, conjunctival hyperemia, extensive ecchymoses at multiple sites on the body, an antecubital hematoma, bilateral basal rales, hepatomegaly, and splenomegaly were observed during the physical examination. The White Blood Cell Count (WBC) was determined to be 1,100/mm3, the Hemoglobin (Hgb) level was 11.8 g/dL, and the platelet count was 10,000/mm3.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (39)

  1. Gulati S, Gulati A. Pulmonary manifestations of leptospirosis. Lung India 2012;29:347-53.
  2. Carvalho CRR, Bethlem EP. Pulmonary complications of leptospirosis. Clin Chest Med 2002;23:469-78.
  3. Lomar AV, Diament D, Torres JR. Leptospirosis in Latin America. Infect Dis Clin North Am 2000;14:23-39.
  4. Seguro ER, Ganoza CA, Campos K, et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis 2005;40:343-51.
  5. Levett PN. Leptospirosis. Clin Microbiol Rev 2001;14:296-326.
  6. O'Neil KM, Rickman LS, Lazarus AA. Pulmonary manifestations of leptospirosis. Rev Infect Dis 1991;13:705-9.
  7. Tanomkiat W, Poonsawat P. Pulmonary radiographic findings in 118 leptospirosis patients. Southeast Asian J Trop Med Public Health 2005;36:1247-51.
  8. Chacko CS, Lakshmi S, Jayakumar A, et al. A short review on leptospirosis: clinical manifestations, diagnosis and treatment. Clin Epidemiol Global Health 2021;11:100741.
  9. Pavli A, Maltezou HC. Travel-acquired leptospirosis. J Travel Med 2008;15:447-53.
  10. Katz AR, Ansdell VE, Effler PV, et al. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998. Clin Infect Dis 2001;33:1834-41.
  11. Morgan J, Bornstein SL, Karpati AM, et al. Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis 2002;34:1593-9.
  12. Puca E, Pilaca A, Kalo T, et al. Ocular and cutaneous manifestation of leptospirosis acquired in Albania: A retrospective analysis with implications for travel medicine. Travel Med Infect Dis 2016;14:143-7.
  13. Rathinam SR, Rathnam S, Selvaraj S, et al. Uveitis associated with an epidemic outbreak of leptospirosis. Am J Ophthalmol 1997;124:71-9.
  14. Sanford JP. Leptospirosis--time for a booster. N Engl J Med 1984;310:524-5.
  15. Vanasco NB, Schmeling MF, Lottersberger J, et al. Clinical characteristics and risk factors of human leptospirosis in Argentina (1999-2005). Acta Trop 2008;107:255-8.
  16. Romero EC, Blanco RM, Yasuda PH. Aseptic meningitis caused by Leptospira spp diagnosed by polymerase chain reaction. Mem Inst Oswaldo Cruz 2010;105:988-92.
  17. Pamplona BE, Carvalho, CRR. Pulmonary leptospirosis. Current Opinion in Pulmonary Medicine 2000;6:436-41.
  18. Early Access Chest Disease Reports Case Report The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries should be directed to the corresponding author for the article. All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
  19. Segura ER, Ganoza CA, Campos K, et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis 2005;40:343-51.
  20. Hurst FP, Neff RT, Katz AR, et al. Acute kidney injury requiring hemodialysis in patients with anicteric leptospirosis. Clin Nephrol 2009;72:186-92.
  21. Dupont H, Dupont-Perdrizet D, Perie JL, et al. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis 1997;25:720-4.
  22. Bethlem EP, Carvalho CRR. Pulmonary leptospirosis. Curr Opin Pulm Med 2000;6:436- 41.
  23. Im JG, Yeon KM, Han MC, et al. Leptospirosis of the lung: Radiographic findings in 58 patients. AJR Am J Roentgenol 1989;152:955-9.
  24. Allen P, Raftery S, Phelan D. Massive pulmonary haemorrhage due leptospirosis. Intensive Care Med. 1989;15:322-4. Poh SC, Soh CS. Lung manifestations in leptospirosis. Thorax 1970;25:751-5.
  25. Silva JJ, Dalston MO, Carvalho JE, et al. Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis. Rev Soc Bras Med Trop 2002;35:395-9.
  26. Pai ND, Adhikari PM. Haemorrhagic pneumonitis: A rare presentation of leptospirosis. J Postgrad Med 2001;47:35-6.
  27. Sonthayanon P, Chierakul W, Wuthiekanun V, et al. Accuracy of loop-mediated isothermal amplification for diagnosis of human leptospirosis in Thailand. Am J Trop Med Hyg 2011;84:614-20.
  28. Koizumi N, Nakajima C, Harunari T, et al. A new loop-mediated isothermal amplification method for rapid, simple, and sensitive detection of Leptospira spp. in urine. J Clin Microbiol 2012;50:2072-4.
  29. Cermakova Z, Kucerova P, Pliskova L, Kubickova P. Real-time PCR method for the detection of the gene encoding surface lipoprotein LipL32 of pathogenic Leptospira: use in the laboratory diagnosis of the acute form of leptospirosis. Scand J Infect Dis 2013;45:593-9.
  30. Waggoner JJ, Pinsky BA. Molecular diagnostics for human leptospirosis. Curr Opin Infect Dis 2016;29:440-5.
  31. Schreier S, Doungchawee G, Chadsuthi S, et al. Leptospirosis: current situation and trends of specific laboratory tests. Expert Rev Clin Immunol 2013;9:263-80.
  32. Levett PN. Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin Infect Dis 2003;36:447-52.
  33. Johnson WD Jr, Silva IC, Rocha H. Serum creatine phosphokinase in leptospirosis. JAMA 1975;233:981-2.
  34. Fontes AP, Ribeiro DP, Jesus LS, et al. Respiratory functional characteristics of human leptospirosis. Rev Soc Bras Med Trop 2010;43:161-5.
  35. Lee RE, Terry SI, Walker TM, Urquhart AE. The chest radiograph in leptospirosis in Jamaica. Br J Radiol 1981;54:939-43.
  36. Matos ED, Costa E, Sacramento E, et al. Chest radiograph abnormalities in patients hospitalized with leptospirosis in the city of Salvador, Bahia, Brazil. Braz J Infect Dis 2001;5:73-7.
  37. Chawalparit O, Charoensak A, Niwattayakul K, et al. Radiographic chest findings and clinical correlations in leptospirosis. J Med Assoc Thai 2007;90:918-24.
  38. Marchiori E, Müller NL. Leptospirosis of the lung: High resolution computed tomography findings in five patients. J Thorac Imaging 2002;17:151-3.
  39. Yang J, Zhang Y, Xu J, et al. Serum activity of platelet activating factor acetylhydrolase is a potential clinical marker for leptospirosis pulmonary hemorrhage. PLoS One 2009;4:e4181.